Skip to main content

Table 4 Treatment response

From: Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

Local response 6 weeks post completion of treatment [pts, (%)], N = 14 4-5 months post completion of treatment [pts, (%)], N = 14 at time of analysis [pts, (%)] N = 14
CR 4 (28.6%) 8 (57.1%) 13 (92.9%)
PR 8 (57.1%) 5 (35.7%) 0
SD 2 (14.3%) 1 (7.1%) 1(7.1%)
PD (locoregional) 0 0 0
PD (distant metastases) 0 1 (7.1%) 3 (21.4%)